Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-19-017362
Filing Date
2019-11-14
Accepted
2019-11-14 14:48:38
Documents
50
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 866359
2 ex31-1.htm EX-31.1 20608
3 ex31-2.htm EX-31.2 20751
4 ex32-1.htm EX-32.1 11811
  Complete submission text file 0001493152-19-017362.txt   3192214

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE ptix-20190930.xml EX-101.INS 486245
6 XBRL SCHEMA FILE ptix-20190930.xsd EX-101.SCH 37205
7 XBRL CALCULATION FILE ptix-20190930_cal.xml EX-101.CAL 37863
8 XBRL DEFINITION FILE ptix-20190930_def.xml EX-101.DEF 138173
9 XBRL LABEL FILE ptix-20190930_lab.xml EX-101.LAB 263709
10 XBRL PRESENTATION FILE ptix-20190930_pre.xml EX-101.PRE 203404
Mailing Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010
Business Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010 (212) 994-8200
Protagenic Therapeutics, Inc.\new (Filer) CIK: 0001022899 (see all company filings)

EIN.: 061390025 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-51353 | Film No.: 191219152
SIC: 7389 Services-Business Services, NEC